4-chloro-7-nitrobenzofurazan has been researched along with thromboxane a2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauman, JE; Joist, JH; Lagunoff, D; Martin, TW | 1 |
Colman, RW; Puri, RN | 1 |
2 other study(ies) available for 4-chloro-7-nitrobenzofurazan and thromboxane a2
Article | Year |
---|---|
Activation of human platelets by N-substituted aminophospholipids.
Topics: 4-Chloro-7-nitrobenzofurazan; Adenosine Diphosphate; Blood Platelets; Cyclic AMP; Epoprostenol; Humans; Indomethacin; Phosphatidylserines; Platelet Aggregation; Serotonin; Theophylline; Thromboxane A2 | 1985 |
Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 4-Chloro-7-nitrobenzofurazan; Adenosine; Adenosine Diphosphate; Blood Platelets; Calcimycin; Calcium; Cell Aggregation; Cell Size; Collagen; Cyclic AMP; Fibrinogen; Humans; Platelet Activation; Platelet Membrane Glycoproteins; Prostaglandin Endoperoxides, Synthetic; Tetradecanoylphorbol Acetate; Thrombin; Thromboxane A2; Time Factors | 1996 |